Department of Pediatrics, Government Medical College, Calicut, Kerala, India.
Department of Pediatrics, KMCT, Kerala, India.
Br J Clin Pharmacol. 2022 Sep;88(9):4217-4219. doi: 10.1111/bcp.15306. Epub 2022 Mar 24.
Pseudotumour cerebri is a manifestation of intracranial hypertension in an otherwise normal individual. We hereby report phenytoin-induced pseudotumour cerebri in a 9-year-old boy who received phenytoin as a prophylactic anticonvulsant following surgical removal of unifocal Langerhans cell histiocytosis involving the right frontal bone. The child was evaluated for headache and diplopia after starting phenytoin and on evaluation was found to have bilateral sixth nerve palsy. The only abnormality detected was an elevated cerebrospinal fluid pressure. Withdrawal of phenytoin resulted in complete resolution of symptoms. Despite meticulous literature search, we found only 1 other report of phenytoin induced pseudotumour cerebri. We report this case to highlight the need to consider this entity whenever a patient presents with new onset or persistent headache and visual symptoms soon after starting a medication since a high degree of suspicion is needed to arrive at the diagnosis and to take appropriate steps before it progresses to harmful complications such as vision loss.
假性脑瘤是一种在其他方面正常的个体中出现的颅内高压表现。我们在此报告一例苯妥英钠引起的假性脑瘤,发生于 9 岁男孩,该男孩因右额骨单发朗格汉斯细胞组织细胞增生症切除术后接受苯妥英钠预防抗惊厥治疗。该患儿在开始使用苯妥英钠后出现头痛和复视,并在评估时发现双侧第六对脑神经麻痹。唯一检测到的异常是脑脊液压力升高。停用苯妥英钠后症状完全缓解。尽管进行了细致的文献检索,我们仅发现另外 1 例由苯妥英钠引起的假性脑瘤的报告。我们报告这个病例是为了强调,每当患者在开始使用药物后出现新发或持续头痛和视觉症状时,都需要考虑到这种情况,因为需要高度怀疑才能做出诊断,并在病情进展到视力丧失等有害并发症之前采取适当措施。